Plus Therapeutics Inc Annual Shareholders Meeting Transcript
Good morning, ladies and gentlemen. I am Marc Hedrick, President and Chief Executive Officer of Plus Therapeutics. And it's my pleasure to welcome all of you. It is now 9 a.m. Central Time on the 16th day of June 2020. And in accordance with the notice of the meeting, I call to order the 2020 Annual Meeting of Stockholders. I will be acting as Chairman of this meeting.
In this meeting, we will consider the proposal set forth in the proxy statement for the annual meeting dated June 16, 2020. After the votes are counted, the meeting will be adjourned. This meeting is held pursuant to the proxy materials mailed on or about May 13, 2020, to each stockholder of record on May 9, 2020 as well as the notice and proxy statement, which were made available at the time of the mailing. As of the close of business on the record date, there were 4,111,357 shares of common stock outstanding and entitled to vote. A list of the stockholders entitled to vote at this meeting has been available at the company headquarters for the past 10 days
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
